Published in Drug Week, February 17th, 2006
"This analysis presents a recruitment, retention, and (treatment and/or research) adherence (RRA) best practices model for targeting Alzheimer disease and associated dementias (ADAD) impacting ethnically diverse populations. RRA practice involves many more factors beyond cultural considerations to be highlighted here," a scientist writing in the journal Alzheimer Disease & Associated Disorders reported.
"However, it is the cultural dimension where much is at stake, where there is the least comprehensive framework, and where the most ambiguity exists...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.